Amy Klobuchar actually said...

"It seems to me the evidence suggests that just putting it back to rule of reason should have--should do the trick based on the evidence that is being adduced by my colleagues on the panel."

"It is the pay-for-delay settlement that we have concerns about, Senator Grassley and I, Senator Vitter and Senator Franken."

"it is entirely proper to put the burden on the drug companies to demonstrate that actually these have a pro-competitive, not anti-competitive impact."

"I have long believed there are speculation issues."